NRGene Technologies Ltd (NRGN) Fair Value & Analysis
Technology · Il · Market cap 29.5M ILA
Fair value as of: Jun 24, 2026
Analysis
NRGene Technologies Ltd (NRGN) currently trades at 2.15 ILA, while our model-based Fair Value estimate is 0.9700 ILA — implying the stock looks roughly 54.9% overvalued today. We read business quality at 94/100 (high quality), in the Technology sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
About the company
NRGene Technologies Ltd operates as a research and development company focusing on intellectual property-intensive technological products in the field of AgTech in North America, Europe, the Middle East, Africa, Asia Pacific, and internationally. It develops and commercializes plant varieties, traits, and animals based on artificial intelligence (AI) technology and software tools for analyzing genetic information. The company also offers Supree semi-dried cherry tomatoes; clubroot-resistant canola; and black soldier fly as an alternative to animal-based protein. Its technology portfolio includes DeNovoMAGIC, a de novo assembly solution that assembles genomes. NRGene Technologies Ltd was incorporated in 2009 and is based in Ness Ziona, Israel.
Open the full interactive analysis →
Similar stocks
Frequently asked questions
Is NRGene Technologies Ltd (NRGN) undervalued?
What is the fair value of NRGN?
What is the quality score of NRGN?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.